Diacetylglycerol

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

DAG

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Diacylglycerol, abbreviated as DAG, is a product that is formed during the enzymatic cleavage of the membrane lipid phosphatidylinositol-4,5-bisphosphate (PIP2) by phospholipase C (PLC). Phosphatidylinositol-4,5-bisphosphate is enzymatically cleaved into the cytosolic inositol trisphosphate (IP3) and into the membrane-bound diacylglycerol.

General informationThis section has been translated automatically.

Diacyglycerol recruits enzymes to the cell membrane and anchors them there. Among other things, diacyglycerol is involved in the activation of protein kinase C (PKC). Protein kinase C phosphorylates enzymes in the cytosol and thus influences gene expression. Studies have shown that hyperglycaemia activates protein kinase C (PKC) and also triggers elevated diacylglycerol (DAG) levels (Koya D et al. 1988). This promotes the production of extracellular matrix and cytokines, increases the contractility and permeability of blood vessels, increases cell growth in blood vessels, activates phospholipase A2 and inhibits Na+/K+-ATPase. As a result, the retina of the eye, kidney and heart are damaged.

LiteratureThis section has been translated automatically.

  1. Koya D et al (1988) Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866.

Authors

Last updated on: 29.10.2020